Programming a fixed long atrioventricular delay is not effective in preventing ventricular pacing in patients with sick sinus syndrome

Europace. 1999 Apr;1(2):113-20. doi: 10.1053/eupc.1998.0026.

Abstract

Aim: Most patients with sick sinus syndrome (SSS) and normal atrioventricular (AV) conduction receive dual chamber (DDDR) pacemakers. Programming a long AV delay has been proposed to avoid ventricular pacing. The present study aimed to evaluate ventricular stimulation in SSS patients with DDDR pacemakers with a long AV delay.

Methods and results: Thirty eight patients treated with DDDR pacemakers with a fixed long AV delay (300 ms) were studied. Data from the pacemaker event recorder were retrieved after 3 months and every year after implantation. Ten patients underwent 24 h Holter recording. Mean follow-up was 11.9 +/- 8.3 months. Median daily number of paced events in the ventricle was 2659 (25th-75th percentiles: 775-21 315) with a large inter-individual variation. The proportion of paced events in the ventricle correlated weakly with the baseline PQ interval (Spearman's rho 0.331, P = 0.043). In 12/38 patients the mean daily number of paced events in the ventricle exceeded 10,000. During 24 h Holter recording, pacemaker arrhythmias caused by repetitive retrograde atrioventricular conduction, known as VA (ventriculoatrial) conduction, occurred in five out of 10 patients.

Conclusion: DDDR pacing with a fixed long AV delay is inefficient in reducing ventricular pacing in one third of patients and is associated with a high risk of arrhythmias caused by repetitive retrograde AV conduction, and therefore cannot be recommended for general use in SSS patients.

Publication types

  • Evaluation Study
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Aged
  • Aged, 80 and over
  • Arrhythmias, Cardiac / prevention & control*
  • Atrioventricular Node / physiology
  • Cardiac Pacing, Artificial / methods*
  • Electrocardiography, Ambulatory
  • Electrophysiology
  • Female
  • Follow-Up Studies
  • Humans
  • Male
  • Risk Factors
  • Sick Sinus Syndrome / physiopathology
  • Sick Sinus Syndrome / therapy*
  • Treatment Outcome
  • Ventricular Function / physiology*